16 results match your criteria: "Oxford University Hospital Foundation Trust[Affiliation]"
Objective: To compare the effectiveness of endometriosis excision alone to excision plus hysterectomy, with and without bilateral oophorectomy, for endometriosis-related symptoms.
Design: Multicentre prospective cohort.
Setting: Eighty-six specialist endometriosis centres.
Eur J Oncol Nurs
June 2024
Oxford Institute of Applied Health Research, Oxford Brookes University, Oxford, United Kingdom; Oxford Health NHS Foundation Trust, The Warneford Hospital, Oxford, United Kingdom.
Purpose: Clinical research trials are needed to enhance the medical care and treatment for lung cancer, which remains the leading cause of cancer-related deaths worldwide. While clinical trials allow for the development of novel therapies to treat cancer, the recruitment of lung cancer patients to trials is low. This review aimed to identify and synthesise the available literature concerning barriers and facilitators affecting lung cancer patients' decisions to enrol in clinical trials to guide future cancer research efforts.
View Article and Find Full Text PDFFuture Healthc J
November 2023
Oxford University Hospital Foundation Trust, Oxford, UK.
Delays and waiting in urgent and emergency care (UEC) services are causing avoidable harm to patients and affecting staff morale. Patients are often having a poor experience of using UEC services, increasing stress and anxiety for both their families and themselves, delaying their recovery. Despite the constraints of available permanent staffing, funding and competing NHS priorities, changes along the whole UEC pathway in and out of hospital, admitted and non-admitted pathways need to be made safe, timely and accessible, to provide clinically appropriate care for patients.
View Article and Find Full Text PDFIntensive Crit Care Nurs
December 2023
Oxford University Hospital Foundation Trust, United Kingdom.
Cancers (Basel)
August 2022
Nuffield Orthopaedic Centre, Oxford University Hospital Foundation Trust, Oxford OX3 7LD, UK.
Neurol Sci
August 2021
Wolfson Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, Wolfson Building , John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK.
Future Healthc J
March 2019
Geratology, Oxford University Hospital Foundation Trust, Oxford, UK.
Insights Imaging
July 2019
Department of Radiology, Nuffield Orthopaedic Centre, Oxford University Hospital Foundation Trust, Windmill Road, Headington, Oxford, OX3 7HE, UK.
Brown tumours do not represent neoplastic process, but they are focal bony lesions due to bone remodelling from either primary or secondary hyperparathyroidism. Their incidence is also low. The current literature on brown tumour is mainly in the form of case reports that focus on single affected sites.
View Article and Find Full Text PDFJ Clin Neurosci
October 2019
Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.
Indirect targeting of the Ventralis Intermedius Nucleus (Vim) is widely used for functional neurosurgical procedures to treat essential tremor (ET). Here, we review if the laterality of the Vim depends on the diameter of the third ventricle and if a targeting approach that incorporates this correlation can facilitate targeting and yields accurate lead placement. We analyzed 15 consecutive ET patients.
View Article and Find Full Text PDFTrials
May 2019
CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Background: Trials have become bigger and more complicated due to the complexity introduced by biomarker stratification, and the advent of multi-arm multi-stage trials, and umbrella and basket platform designs. The trials unit at University College London has been at the forefront of this work, with ground-breaking trials such as STAMPEDE and FOCUS4. The trial management and data management teams on these trials have summarised the operational challenges, to enable the broader clinical trials community to learn from their experiences.
View Article and Find Full Text PDFCephalalgia
August 2019
3 Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK.
Objective: We present long-term follow-up results and analysis of stimulation sites of a prospective cohort study of six patients with chronic cluster headaches undergoing deep brain stimulation of the ipsilateral posterior hypothalamic region.
Methods: The primary endpoint was the postoperative change in the composite headache severity score "headache load" after 12 months of chronic stimulation. Secondary endpoints were the changes in headache attack frequency, headache attack duration and headache intensity, quality of life measures at 12, 24, and 48 months following surgery.
Genet Med
October 2018
Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
Purpose: Fresh-frozen (FF) tissue is the optimal source of DNA for whole-genome sequencing (WGS) of cancer patients. However, it is not always available, limiting the widespread application of WGS in clinical practice. We explored the viability of using formalin-fixed, paraffin-embedded (FFPE) tissues, available routinely for cancer patients, as a source of DNA for clinical WGS.
View Article and Find Full Text PDFBiomed Hub
November 2017
Professor of Cancer and Global Health, KCL, Director, Institute of Cancer Policy and co-Director of King's Conflict and Health Research Group.
The biomedical paradigm of personalised precision medicine - identification of specific molecular targets for treatment of an individual patient - offers great potential for treatment of many diseases including cancer. This article provides a critical analysis of the promise, the hype and the pitfalls attending this approach. In particular, we focus on 'molecularly unstratified' patients - those who, for various reasons, are not eligible for a targeted therapy.
View Article and Find Full Text PDFInt J Stroke
August 2017
6 Ultrasonic Angiology Department, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Background Sickle cell disease (SCD) is one of the most common causes of stroke in children worldwide. Based on the results of the Stroke Prevention Trial in Sickle Cell Anemia (STOP), annual transcranial Doppler ultrasound (TCD) screening for affected children is standard practice. However, the need for TCD surveillance programs could override the accuracy of the screening, affecting the correct stratification of stroke risk and subsequent clinical management of the target population.
View Article and Find Full Text PDFLangenbecks Arch Surg
December 2015
Department of Surgery, Hospital Del Mar, Barcelona, Spain.